Specialty Pharma ApS: Financial statements 2022
CVR: 38476599
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Specialty Pharma ApS (CVR 38476599) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,023,437 and a net result of DKK 41,127 compared with DKK -44,231 the year before. That is an increase of 60.1% compared with the year before. Equity in the 2022 report amounted to DKK 13,816. The solvency ratio was 11.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,023,437
- Profit/Loss
- DKK 41,127
- Equity
- DKK 13,816
- Total Assets
- DKK 115,778
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1 mio. | 41 t. | 14 t. | 1 |
| 2021 | - | 639 t. | -44 t. | -27 t. | 2 |
| 2020 | - | 944 t. | -39 t. | 17 t. | 2 |
| 2019 | - | 819 t. | -14 t. | 56 t. | 2 |
| 2018 | - | 110 t. | -2 t. | 71 t. | 1 |
Official annual report
Keep an eye on Specialty Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Specialty Pharma ApS has published its annual report for 2021. Gross profit came to DKK 639,301, and the net result was DKK -44,231.
About Specialty Pharma ApS
Specialty Pharma ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Ulla Haaning Singapuri. The company is owned by Ulla Haaning Singapuri. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 216,735 and a net result of DKK -58,566 compared with DKK -53,758 the year before. Equity in the 2025 report amounted to DKK -17,816.